Plasma hTERT mRNA discriminates between clinically localized and locally advanced disease and is a predictor of recurrence in prostate cancer patients.
about
Cell-free circulating plasma hTERT mRNA is a useful marker for prostate cancer diagnosis and is associated with poor prognosis tumor characteristicsJoint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significanceThe present and future of prostate cancer urine biomarkers.Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology.Potential clinical significance of perioperative levels of mRNA in plasma from patients with cancer of the larynx or hypopharynx.
P2860
Plasma hTERT mRNA discriminates between clinically localized and locally advanced disease and is a predictor of recurrence in prostate cancer patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Plasma hTERT mRNA discriminate ...... e in prostate cancer patients.
@en
Plasma hTERT mRNA discriminate ...... e in prostate cancer patients.
@nl
type
label
Plasma hTERT mRNA discriminate ...... e in prostate cancer patients.
@en
Plasma hTERT mRNA discriminate ...... e in prostate cancer patients.
@nl
prefLabel
Plasma hTERT mRNA discriminate ...... e in prostate cancer patients.
@en
Plasma hTERT mRNA discriminate ...... e in prostate cancer patients.
@nl
P2093
P2860
P1476
Plasma hTERT mRNA discriminate ...... e in prostate cancer patients.
@en
P2093
Francisco Dasí
José A March-Villalba
José M Martínez-Jabaloyas
José Santamaría
Salvador F Aliño
P2860
P304
P356
10.1517/14712598.2012.685716
P407
P478
12 Suppl 1
P577
2012-05-05T00:00:00Z